OSP FO# 11-185
AGENCY: Department of Health and Human Services (DHHS)/National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA)
OBJECTIVES: This program provides funding to develop and validate a reliable remote real-time cocaine monitoring system for use by clinical trials researchers testing cocaine dependence treatments. Systems will leverage developments in behavioral and/or biometric sensing, mobile and wireless technology and real time data analysis to detect cocaine use in vivo.
Completed systems will include hardware, software, storage and analysis solutions to provide for secure encrypted storage on devices, secure encrypted transmission to a database, and secure researcher interfaces from which data may be aggregated to plot and display data demonstrating clinically meaningful changes in cocaine consumption patterns by individual participants. The system will include safeguards to ensure the behavioral and/or biological data gathered was sampled from the actual participant enrolled by including reliable identity verification measures and protection against tampering and hacking. It will also include “timestamp” information to ensure data sampled was sampled at the times and for the durations specified by researchers. All hardware and software will be developed to ensure the system meets accepted standards for selectivity and specificity to identify cocaine. All hardware, software and databases will undergo sufficiently rigorous testing to be consistent with FDA medical device and software validation guidelines and the entire system will be Health Insurance Privacy and Portability Act (HIPPA) compliant.
Please see the program announcement below for further program details.
DEADLINES: August 18, 2011
FUNDING INFORMATION: This program will utilize the NIH Research Project Grant (R01) award mechanism, and “Just-in-Time” information concepts. NIDA intends to commit $1 million in FY 2012. Between 2-4 awards are anticipated. Budgets of up to $300,000 per year in direct costs may be requested. The maximum project period is 2 years.
Cecelia McNamara Spitznas, Ph.D.
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
6001 Executive Boulevard, Suite 4243, MSC 9550
Bethesda, MD 20892-9550
Phone: (301) 443-0107
REMARKS: NIH requires that applications to this program be submitted electronically through Grants.gov (http://www.grants.gov). After submission via Grants.gov, applications will be retrieved and processed by the NIH Commons system (https://commons.era.nih.gov/commons/index.jsp). In order to prepare a responsive application, PIs should download both the complete program guidelines (RFA-DA-12-007) and the corresponding application package from Grants.gov as well as the NIH Grants.gov Application Guide (http://grants.nih.gov/grants/funding/424/index.htm). PIs must also be registered Commons users.
For more information about Grants.gov and the NIH Commons, or to register as a Commons user, please contact either India Adams (firstname.lastname@example.org) or A. B. Effgen (email@example.com) in the Office of Sponsored Programs (OSP) at x3-4365. In addition, please contact the OSP Assistant Director assigned to your school or department as soon as possible to coordinate submission through the Grants.gov system.
Complete program guidelines and application material may be obtained from the web site listed above or from the Office of Sponsored Programs (OSP). Please distribute this notice to any faculty or staff members who might be interested in the information. For more information, please contact the OSP at X3-4365 or firstname.lastname@example.org, or visit the OSP web site at http://www.bu.edu/osp.